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~Burkholderia cepacia complex isolation and identification in a 
Turkish CF Unit 
R Yurdakul 1, K. Ergiinay 1, E. Yalcin 2, D. Dogru 2, B. Sener 1, N. Cobanoglu 2,
U. Ozcelik 2, N. Kiper 2. 1Dept. of Clinical Microbiology, 2pediatric Pulmonology 
Unit, Hacettepe Univ. Medical Faculty, Ankara, Turkey 
Introduction: Isolation of B. cepacia complex (Bcc) in sputum from CF patients 
carries a significant medical importance. Rapid and precise identification is essential 
to evaluate risks in terms of prognosis and epidemicity. This study was performed 
to evaluate the prevalence and genomovar status of Bcc in our CF population. 
Methods: Sputum samples colllected from 92 CF patients were inoculated onto 
OFBL agar for the isolation of Bcc. Phoenix@ Identification System was used for 
phenotypic analysis. Nucleic acid purification from sputum was performed using 
High Pure PCR Template Kit©. Bcc rec A gene was amplified utilizing BCR-1 and 
BCR-2 primers. Bcc strain KK 7394 (Neqas, UK) was used as reference strain and 
P putida as negative control. For the validation of PCR, another CF sputum with no 
pathogenic bacterial growth was spiked with 107 cfu/ml reference strain. Restriction 
fragment length polymorphism (RFLP) was done for the molecular identification 
of Bcc isolate. 
Results: Bcc was isolated from 2 out of 92 samples (2.2%) and phenotypically 
verified using the automatized system. PCR was shown to detect DNAs from 
reference strain, spiked sample and one of the sputum samples from which Bcc 
was isolated (1.1%). RecA PCR (+) strain was identified as B. multivorans by 
RFLR 
Conclusion: Although Bcc is an infrequent pathogen i  our CF population, special 
care should be given for its isolation and identification since it has considerable 
impact on morbidity and mortality in CE Identification of putative Bcc isolates 
should be confirmed by molecular methods as misidentification may occur when 
only phenotypic analysis is considered. 
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~ Assessment of molecular methods for the rapid identification of 
Burkholderia cepacia complex (Bcc)-positive sputa 
A.R. Brown, J.R.W Govan. The Centre for Inj~ctious Diseases, University of 
Edinburgh, UK 
Aims: Early implementation of appropriate antimicrobial therapy and infection 
control measures is reliant on the rapid and accurate diagnosis of respiratory 
infections. Whilst culture-based methods with subsequent biochemical analysis and 
species-specific PCR oiler reliable identification, this process may take up to a 
week when applied to sputa, particularly if bacterial counts are low or isolates 
atypical. The current segregation policy for CF patients with Bcc infection does 
not distinguish between genomovars. Accordingly, this study aims to assess non- 
culture-based methods (PCR and fluorescent in situ hybridization, FISH) for the 
identification of Bcc-positive sputa within 2 3 hours. 
Methods: The study will compare commercially-available FISH reagents (SeaPro 
Theranostics) with a Bcc-specific in-house PCR assay (targeted against 16S rRNA 
sequence) for the identification of Bcc organisms within CF sputa. 
Results: In a preliminary blind study of 100 CF isolates (including 37 Bcc, 1 non- 
Bcc Burkholderia, 33 Pseudomonads, 10Achromobacter xylosoxidans, 2 Ralstonia 
sp., 1 Pandoraea sp.) the Bcc PCR assay exhibited a sensitivity and specificity of 
97% (36/37) and 100% (37/37) respectively. The single false-negative, a B. multi- 
vorans isolate, was positive upon re-testing. A comparable study will be performed 
to assess the specificity of FISH for the Bcc. Following optimization, the PCR- and 
FISH-based assays will be applied to CF sputa, and results compared with those 
obtained by conventional methods. The results of this comparison will be presented. 
Conclusions: By assessing rapid molecular methods for the identification of Bcc 
within CF sputa, this study aims to improve on existing diagnostic methods and 
enhance the management of Bcc infections in CF patients. 
• Clinical features of Pseudomonas aeruginosa (Pa) negative 
cystic fibrosis (CF) patients with the history of Pa infection 
V Vavrova, J. Bartosova, L. Fila, V Skalicka, J. Brazova, K. Bohmova, 
S. Vosahlikova, R Pohunek, D. Zemkova. CF Centre, Charles University 
2rid Medical School and University Hospital Motol, Prague, Czech Republic 
In our Prague CF Centre, we have observed an increasing number of Pa negative 
patients with the history of Pa infection (Pa free patients). Here we studied 
clinical peculiarities in these patients. Overall 39/209 sputum producers had Pa 
negative culture for at least 1 year (2.8±1.6). Their age and lung function were 
compared with groups of Pa negative patients (n 39), Pa intermittent positive 
patients (n 49), patients with Pa chronic colonization, and Burkholderia cepacia 
complex (Bcc) cases (n 54). Pa free patients were younger than patients with Pa 
chronic colonization and Bcc infected cases, and had similar age as Pa negative 
and intermittent positive group. With regards to lung function 56.2% of patients 
had FEV1 higher than 80% p.v. and 6.3% of patients had FEV1 lower than 40% 
p.v. Compared to Pa negative patients, they had a tendency towards FEV1 lower 
than 70% p.,~ (p 0.07). FEV1 of Pa free patients older than 18 years tends to be 
similar to FEV1 in Bcc infected cases. 
All Pa free patients were PCR negative and most of the Pa free patients with FEV1 
lower than 70% p.,~ had negative anti-Pa antibodies. Our unfavourable findings 
were not caused by false negative cultures. We suppose that these results in older 
Pa free patients could be due to irreversible changes that have developed uring Pa 
infection and/or less vigilant antibiotic treatment after repeatedly negative cultures. 
Therefore, we consider that early diagnosis of the pathogen and an aggressive 
treatment of Pa primo-infection are necessary. 
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1• Identification of Burkholderia cepacia complex using MALDI-TOF 
mass spectrometry 
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The identification of organisms cultured from respiratory specimens obtained from 
CF patients is not straightforward and misidentifications occur. We evaluated 
the identification of Burkholderia cepacia complex (Bcc)-like organisms using 
Matrix Assisted Laser Desorption/Ionisation Time Of Flight mass spectrometry 
(MALDI-TOF MS) of intact microbial cells. In this technique, laser light vaporizes 
biomolecules achieving free gas-phase ions that were separated by their mass-to- 
charge ratios. We investigated 60 Bcc strains and 40 non-Bcc strains representing 
20 species that are commonly misidentified as Bcc. Colonies grown for 24h were 
suspended in 0.5 ml 0.1% TFA, 2 gl of which was mixed with 2 gl matrix solvent 
(49 ACN: 49 Isopropanol: 2 0.1% TFA saturated with alpha-cyano). Subsequently 
1 gl was spotted for analysis. 
We obtained bacterial mass spectra in the m/z range 2 18 kDa. The data were anal- 
ysed by Bionumerics 4.0 software and subjected to a cluster analysis using Pearson's 
correlation coefficient. Except for BurkhoMeria gladioli and some Ralstonia sT., 
all reference species were easily distinguished from Bcc. Most strains belonging to 
Bcc species grouped in species pecific clusters, except for Burkholderia pyrrocinia 
and BurkhoMeria nthina that constitute a single cluster. The same was observed 
for most of the other taxa examined. In the mass spectra some peaks could be used 
as biomarkers to distinguish between species or even strains. Moreover, this method 
is quick, easy to perform and rather cheap. 
These data suggest that MALDI-TOF MS of intact cells could be a powerful tool 
for the rapid identification of Bcc-like organisms recovered from CF patients. 
